Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2025-03-05 Sale |
2025-03-07 4:38 pm |
Metagenomi Inc. | MGX | Wein Matthew See Remarks |
930 | $1.8748 | $1,744 | 9,467 (Direct) |
View |
2025-03-05 Sale |
2025-03-07 4:36 pm |
Metagenomi Inc. | MGX | Wapnick Pamela Chief Financial Officer |
1,808 | $1.8748 | $3,390 | 59,684 (Direct) |
View |
2024-12-05 Sale |
2024-12-06 4:24 pm |
Metagenomi Inc. | MGX | Wapnick Pamela Chief Financial Officer |
1,559 | $1.86 | $2,900 | 61,492 (Direct) |
View |
2024-09-05 Sale |
2024-09-06 5:14 pm |
Metagenomi Inc. | MGX | Wapnick Pamela Chief Financial Officer |
6,265 | $2.88 | $18,043 | 63,051 (Direct) |
View |
2024-02-09 Purchase |
2024-02-15 8:38 pm |
Metagenomi Inc. | MGX | Novo Holdings A/S 10% Owner |
900,000 | $14.47 | $13,025,000 | 1,739,175 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2025-04-01 Option Award |
2025-04-03 11:58 am |
N/A 2035-03-31 |
Metagenomi Inc. | MGX | Wapnick Pamela Chief Financial Officer |
98,000 | $0 | 157,684 (Direct) |
View |
2025-04-01 Option Award |
2025-04-03 11:58 am |
N/A 2035-03-31 |
Metagenomi Inc. | MGX | Thomas Brian C. Chief Executive Officer |
228,000 | $0 | 2,724,276 (Direct) |
View |
2025-04-01 Option Award |
2025-04-03 11:57 am |
N/A 2035-03-31 |
Metagenomi Inc. | MGX | Irish Jian See Remarks |
163,000 | $0 | 818,898 (Direct) |
View |
2025-04-01 Option Award |
2025-04-03 11:57 am |
N/A 2035-03-31 |
Metagenomi Inc. | MGX | Wein Matthew See Remarks |
52,025 | $0 | 61,492 (Direct) |
View |
2025-04-01 Option Award |
2025-04-03 11:56 am |
N/A 2035-03-31 |
Metagenomi Inc. | MGX | Noonberg Sarah B. Chief Medical Officer |
98,000 | $0 | 198,374 (Direct) |
View |
2025-02-03 Option Award |
2025-02-05 4:24 pm |
N/A 2035-02-02 |
Metagenomi Inc. | MGX | BJERKHOLT ERIC Director |
42,000 | $0 | 42,000 (Direct) |
View |
2024-04-01 Option Award |
2024-04-03 9:10 pm |
N/A 2034-03-31 |
Metagenomi Inc. | MGX | Irish Jian See Remarks |
366,779 | $0 | 952,206 (Direct) |
View |
2024-04-01 Option Award |
2024-04-03 9:08 pm |
N/A 2034-03-31 |
Metagenomi Inc. | MGX | Eckhardt Juergen Director |
78,636 | $0 | 78,636 (Direct) |
View |
2024-04-01 Option Award |
2024-04-03 8:59 pm |
N/A 2034-03-31 |
Metagenomi Inc. | MGX | Borges Luis Chief Scientific Officer |
360,766 | $0 | 360,766 (Direct) |
View |
2024-04-01 Option Award |
2024-04-03 8:57 pm |
N/A 2034-03-31 |
Metagenomi Inc. | MGX | Wein Matthew See Remarks |
54,114 | $0 | 54,114 (Direct) |
View |
2024-04-01 Option Award |
2024-04-03 8:52 pm |
N/A 2034-03-31 |
Metagenomi Inc. | MGX | Wapnick Pamela Chief Financial Officer |
360,766 | $0 | 360,766 (Direct) |
View |
2024-04-01 Option Award |
2024-04-03 8:47 pm |
N/A 2034-03-31 |
Metagenomi Inc. | MGX | Noonberg Sarah B. Chief Medical Officer |
300,638 | $0 | 343,249 (Direct) |
View |
2024-04-01 Option Award |
2024-04-03 8:44 pm |
N/A 2034-03-31 |
Metagenomi Inc. | MGX | Bernales Sebastian Director |
78,636 | $0 | 78,636 (Direct) |
View |
2024-04-01 Option Award |
2024-04-03 8:40 pm |
N/A 2034-03-31 |
Metagenomi Inc. | MGX | Harnest Simon See Remarks |
60,127 | $0 | 171,239 (Direct) |
View |
2024-04-01 Option Award |
2024-04-03 8:18 pm |
N/A 2034-03-31 |
Metagenomi Inc. | MGX | Delaney Simren See Remarks |
36,076 | $0 | 123,037 (Direct) |
View |
2024-04-01 Option Award |
2024-04-03 8:11 pm |
N/A 2034-03-31 |
Metagenomi Inc. | MGX | Dere Willard H Director |
78,636 | $0 | 78,636 (Direct) |
View |
2024-04-01 Option Award |
2024-04-03 8:00 pm |
N/A 2034-03-31 |
Metagenomi Inc. | MGX | Thomas Brian C. Chief Executive Officer |
619,315 | $0 | 2,996,599 (Direct) |
View |
2024-02-13 Conversion |
2024-02-15 8:38 pm |
N/A N/A |
Metagenomi Inc. | MGX | Novo Holdings A/S 10% Owner |
1,678,350 | $0 | 1,739,175 (Direct) |
View |
2024-02-13 Conversion |
2024-02-15 5:59 pm |
N/A N/A |
Metagenomi Inc. | MGX | BAYER HEALTHCARE LLC Bayer US Holding LP Bayer World Investments B.V. BAYER AKTIENGESELLSCHAFT 10% Owner |
11,127,721 | $0 | 4,050,997 (Direct) |
View |
Ownership |
2024-02-15 5:03 pm |
N/A N/A |
Metagenomi Inc. | MGX | BAYER HEALTHCARE LLC Bayer US Holding LP Bayer World Investments B.V. BAYER AKTIENGESELLSCHAFT 10% Owner |
0 | $0 | 4,050,997 (Direct) |
View |
2024-02-13 Conversion |
2024-02-14 4:29 pm |
N/A N/A |
Metagenomi Inc. | MGX | Bernales Sebastian Director |
6,618,541 | $0 | 3,068,786 (Direct) |
View |
Ownership |
2024-02-08 8:37 pm |
N/A N/A |
Metagenomi Inc. | MGX | Novo Holdings A/S 10% Owner |
0 | $0 | 839,175 (Direct) |
View |
Ownership |
2024-02-08 7:26 pm |
N/A N/A |
Metagenomi Inc. | MGX | Noonberg Sarah B. Chief Medical Officer |
0 | $0 | 42,611 (Direct) |
View |
Ownership |
2024-02-08 7:24 pm |
N/A N/A |
Metagenomi Inc. | MGX | Bernales Sebastian Director |
0 | $0 | 3,068,786 (Direct) |
View |
Ownership |
2024-02-08 7:23 pm |
N/A N/A |
Metagenomi Inc. | MGX | Harnest Simon See Remarks |
0 | $0 | 111,112 (Direct) |
View |
Ownership |
2024-02-08 7:20 pm |
N/A N/A |
Metagenomi Inc. | MGX | Delaney Simren See Remarks |
0 | $0 | 86,961 (Direct) |
View |
Ownership |
2024-02-08 7:16 pm |
N/A N/A |
Metagenomi Inc. | MGX | Thomas Brian C. Chief Executive Officer |
0 | $0 | 2,377,284 (Direct) |
View |
Ownership |
2024-02-08 7:11 pm |
N/A N/A |
Metagenomi Inc. | MGX | Dere Willard H Director |
0 | $0 | 51,275 (Direct) |
View |
Ownership |
2024-02-08 7:11 pm |
N/A N/A |
Metagenomi Inc. | MGX | Irish Jian See Remarks |
0 | $0 | 585,427 (Direct) |
View |